Caribou Biosciences (CRBU) Treasury Shares (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Treasury Shares data on file, last reported at $3.0 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 36.16% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $3.0 million, a 36.16% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 67.52% from the prior year.
• Treasury Shares for Q1 2026 stood at $3.0 million, up from $2.2 million in the prior quarter.
• Over the last five years, Treasury Shares for CRBU reached as high as $3.0 million in Q1 2026 and fell as low as $60000.0 in Q1 2022.
• Historically, Treasury Shares has averaged $1.1 million across 5 years, with a median of $1.2 million in 2024.
• Across the five-year window, Treasury Shares sank 99.58% in 2022 and soared 673.49% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $256146.0 in 2022, then declined by 19.83% to $205357.0 in 2023, then soared by 531.74% to $1.3 million in 2024, then surged by 67.52% to $2.2 million in 2025, then surged by 38.95% to $3.0 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $3.0 million in Q1 2026, $2.2 million in Q4 2025, and $2.2 million in Q3 2025.